
Martijn Hoogenboom
PhD, Clinical Collaboration Manager at Soteria Medical BV @ The Randstad, Netherlands
CEO/Chief Investment Officer at Xerion Investments; Board of Directors of Global Virus Network (GVN.org) & Cancer Expert Now.
New York City Metropolitan Area
Founder of Xerion Investments, subsidiaries Xerion Precision Biosciences and Xerion.io. Multi-asset class investor in public & private markets.
Founder & Chief Investment Officer of $3.25 Billion Xerion Hedge Funds: 12-yr ('03-'14) net aggregate returns +240%/12.5% IRR; +112%/21% IRR through financial crisis and recovery ('07-'10). Policy analyst, social entrepreneur, former economic policy/legal adviser (privatization/M & A/restructuring).
Xerion.io: Private "Integrated Virtualization" investment company. Investor & advisory boards of selected growth investments in AIaaS (applied artificial intelligence as-a-service), UCaaS (unified communications as-a-service) and data-related MedTech.
Xerion Precision Biosciences: Investing in the transition of medical services from generalized protocols to data-driven personalized, precision medicine; systems biology approaches to detecting, intercepting, preempting, preventing complex chronic diseases.
Board of Directors, Global Virus Network; Corporate Advisory Board, Cancer Expert Now; Finance Committee, Healthy Brain Global Initiative. Member, Council on Foreign Relations; Co-Founder, No Labels (advancing Congressional collaboration).
__________________
daniel.arbess@xerioncapital.com
PhD, Clinical Collaboration Manager at Soteria Medical BV @ The Randstad, Netherlands
RT embedded Software Engineer at BT9 Ltd. @ Israel
Travel technology professional | Helping companies return to travel sooner and safer @ Stephenville, Texas